PICO Portalanswers from OpenAlex
Barricaid (United States)
InstitutionResearch output, impact & collaborations
Barricaid (United States) is a institution indexed in PICO Portal from OpenAlex.
What is known about Barricaid (United States)?
PICO Portalrecord summary
Barricaid (United States) is a research organisation in Woburn, US. OpenAlex records 60 works and 2,250 citations for it. 42 researchers list it as their most recent affiliation.
How many works does Barricaid (United States) have?
PICO Portalindexed works
Barricaid (United States) has 60 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Barricaid (United States) have?
PICO Portalcitation count
Barricaid (United States) has 2,250 citations in the OpenAlex counts PICO Portal stores.
How many researchers are at Barricaid (United States)?
PICO Portalresearcher count
Barricaid (United States) has 42 researchers in the PICO Portal index.
What is the average h-index at Barricaid (United States)?
PICO Portalavg h-index
Barricaid (United States) has an average h-index of 52 in OpenAlex.
What is the ROR of Barricaid (United States)?
PICO Portalror
The ROR for Barricaid (United States) is on the source record.
What is the OpenAlex record for Barricaid (United States)?
PICO Portalopenalex
The OpenAlex for Barricaid (United States) is on the source record.
Who are the most-cited researchers behind Barricaid (United States)?
PICO Portaltop researchers by citations
What are the most-cited papers on Barricaid (United States)?
PICO Portalmost cited works
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan Jagasia, Hildegard Greinix, Mukta Arora, Kirsten M. Williams, Daniel Wolff, Edward W. Cowen, Jeanne Palmer, Daniel J. Weisdorf, Nathaniel S. Treister, Guang‐Shing Cheng, Holly Kerr, Pamela Stratton, Rafael F. Duarte, George B. McDonald, Yoshihiro Inamoto, Afonso Celso Vigorito, Sally Arai, Manuel B. Datiles, David A. Jacobsohn, Theo Heller, Carrie L. Kitko, Sandra A. Mitchell, Paul J. Martin, Howard M. Shulman, Roy S. Wu, Corey Cutler, Georgia B. Vogelsang, Stephanie J. Lee, Steven Z. Pavletic, Mary E.D. Flowers
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
Madan Jagasia, Mukta Arora, Mary E.D. Flowers, Nelson J. Chao, Philip L. McCarthy, Corey Cutler, Álvaro Urbano-Ispizúa, Steven Z. Pavletic, Michael Haagenson, Mei-Jie Zhang, Joseph H. Antin, Brian J. Bolwell, Christopher Bredeson, Jean‐Yves Cahn, Mitchell S. Cairo, Robert Peter Gale, Vikas Gupta, Stephanie J. Lee, Mark R. Litzow, Daniel J. Weisdorf, Mary M. Horowitz, Theresa Hahn
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
David B. Miklos, Corey Cutler, Mukta Arora, Edmund K. Waller, Madan Jagasia, Iskra Pusic, Mary E.D. Flowers, Aaron C. Logan, Ryotaro Nakamura, Bruce R. Blazar, Yunfeng Li, Stephen Chang, Indu Lal, Jason A. Dubovsky, Danelle F. James, Lori Styles, Samantha Jaglowski
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aleksandr Lazaryan, Aravind Ramakrishnan, Zachariah DeFilipp, Amandeep Salhotra, Wanxing Chai‐Ho, Rohtesh S. Mehta, Trent Wang, Mukta Arora, Iskra Pusic, Ayman Saad, Nirav N. Shah, Sunil Abhyankar, Carlos Bachier, John P. Galvin, Annie Im, Amelia Langston, Jane L. Liesveld, Mark Juckett, Aaron C. Logan, Levanto Schachter, Asif Alavi, Dianna S. Howard, Harlan W. Waksal, John L. Ryan, David Eiznhamer, Sanjay Aggarwal, Jonathan Ieyoub, Olivier Schueller, Laurie Green, Zhongming Yang, Heidi Krenz, Madan Jagasia, Bruce R. Blazar, Steven Z. Pavletic
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study
Jason Chesney, Karl D. Lewis, Harriet M. Kluger, Omid Hamid, Eric D. Whitman, Sajeve Thomas, Martin Wermke, Mike Cusnir, Evidio Domingo‐Musibay, Giao Q. Phan, John M. Kirkwood, Jessica C. Hassel, Marlana Orloff, James Larkin, Jeffrey S. Weber, Andrew J.S. Furness, Nikhil I. Khushalani, Theresa Medina, Michael E. Egger, Friedrich Graf Finckenstein, Madan Jagasia, Parameswaran Hari, Giri Sulur, Wen Shi, Xiao Wu, Amod A. Sarnaik
How much of the research on Barricaid (United States) is open access?
PICO Portalopen access share
83%OPEN ACCESS